SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-23-020189
Filing Date
2023-04-25
Accepted
2023-04-25 16:04:57
Documents
6
Period of Report
2023-06-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20007681x1_def14a.htm DEF 14A 719869
2 ny20007681x1-pc_1.jpg GRAPHIC 621638
3 ny20007681x1-pc_2.jpg GRAPHIC 455203
4 ny20007681x1_linechart1x2.jpg GRAPHIC 90830
5 ny20007681x1_linechart2x2.jpg GRAPHIC 86366
6 sig_douglaslovex1.jpg GRAPHIC 11471
  Complete submission text file 0001140361-23-020189.txt   2462674
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

IRS No.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39402 | Film No.: 23844842
SIC: 2834 Pharmaceutical Preparations